The results showed that the high expression of the four FRGs was strongly associated with PDCD1, LAG3, HAVCR2, CTLA-4, and TIGIT in HCC, suggesting that targeting ferroptosis may enhance the efficacy of immunotherapy in HCC. Here, TIGIT is linked to hepatocellular carcinoma.